Global Biologics Market Report Forecasts to 2024

1. Global Biologics Market Report Forecasts to 2024 Global Biologics Market Drivers, Opportunities, Trends, & Forecasts 2018-2024 https://www.infoholicresearch.com/report/biologics-market-research-2024/

2. The market for biologics is driven by increasing incidence of disease across the globe, increasing number of biologics approvals and emergence of next generation biologics such as cell and gene therapy. Strong pipelined products and huge number of ongoing clinical trials are providing market growth opportunity. Challenges associated with biologics production, high cost of the drug, increasing number of biologics going off patent and emergence of biosimilars are hampering market growth. 121 Pages|32 Tables |48 Charts |14 Companies |9 Countries |10 Enquiry Hours https://www.infoholicresearch.com/report/biologics-market-research-2024/

3. Key Players F. Hoffmann-La Roche, Amgen, Inc., Sanofi S.A., Novo Nordisk A/S, Johnson and Johnson, AbbVie, Inc., Novartis AG, GlaxoSmithKline plc, Bristol-Myers Squibb, Merck & Co., Eli Lilly & Company Ltd., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company and other predominate and niche players. 121 Pages|32 Tables |48 Charts |14 Companies |9 Countries |10 Enquiry Hours https://www.infoholicresearch.com/report/biologics-market-research-2024/

4. Competitive Analysis Currently cancer segment dominates the global biologics segment. Biologics are entering new therapeutic areas such as, asthma and allergy where they are not present historically. The key market players are taking the advantage of strategic deals and product approvals to increase their share in the market. For instance, in September 2017, GSK and AbCellera Biologics, Inc. entered an antibody discovery research collaboration, for the discovery of monoclonal antibodies against an undisclosed membrane protein target. In August 2017, Novartis received first FDA approval from FDA for CAR-T cell therapy, Kymriah to treat patients with B-cell precursor acute lymphoblastic leukemia (ALL) and in May 2018, Novartis received second FDA approval for Kymriah to treat patients with B-cell lymphoma. https://www.infoholicresearch.com/report/biologics-market-research-2024/

5. Market Analysis: • The “Global Biologics market” is estimated to witness a CAGR of 9.9% during the forecast period 2018–2024. The global market is analyzed based on three segments – Product, Application and regions. • The market by product is segmented into monoclonal antibodies, recombinant proteins/hormones, vaccines, cell and gene therapy and others. Monoclonal antibodies occupied major market share of global biologics market in 2017 and cell and gene therapy is expected to grow at high CAGR during the forecasted period. Wide application of monoclonal antibodies in treatment of various diseases makes this segment, a major shareholder of biologics products market. Product Analysis:

6. Key Stakeholders

7. Methodology Infoholic Research’s holistic 360 degree approach ensures the delivery of highest quality information valuable to our clients. The information is collated via a combination of primary and secondary research with optimum mix of demand and supply side sources along with thorough top-down / bottom-up validation to provide actionable analysis and insights. Views and information gathered from stakeholder participation and discussions within each market segment, are instrumental aspects of achieving the best results. Summarization of the research methodology matrix and some of the key sources utilized have been provided below as

8. Contact Us Mr. SreenivasanInfoholic Research45/1, Residency Road Cross,5th Floor, Leo Shopping Complex, Bengaluru – 560025, IndiaEmail: sales@infoholicresearch.com https://www.linkedin.com/company/infoholic-research/ https://www.infoholicresearch.com/report/biologics-market-research-2024/

9. About Infoholic Research Infoholic Research (https://www.infoholicresearch.com/)is a global market research and consulting organization providing strategic and high-level market intelligence in emerging and niche markets in Healthcare, ICT, Semiconductors, Chemicals & Materials domain. We aim at delivering high-quality results to our clients providing them with in-depth industry insights to identify new business opportunities and nurture their business strategies. Our team of analysts spanning verticals such as ICT, Healthcare, Chemicals and Semiconductors creates extensive Market Research reports every month covering market trends and dynamics envisioning the road ahead. We also have a Newsletter wherein we keep on featuring guest columns from domain experts, tête-à-tête with leaders and likewise. Additionally, our insightful blogs and articles truly keep the readers hooked. You may also send in your requests for getting our analysts’ viewpoints in specific areas of Healthcare, ICT, Chemicals & Materials, and Semiconductors to validate a certain market trend/ insight or finding. Please let me know how we both can create a cohesive quotient and associate for creating a win-win situation for both of us. https://www.infoholicresearch.com/report/biologics-market-research-2024/